| Literature DB >> 35592592 |
Melese Shenkut Abebe1, Girma Seyoum2, Bahru Emamu3, Demissie Teshome4.
Abstract
Introduction: Congenital hydrocephalus is one of the commonest congenital anomalies of the central nervous system. It is characterized by extensive accumulation of cerebrospinal fluid within the ventricles of the brain due to an imbalance between synthesis and absorption of cerebrospinal fluid. This study was planned to investigate the incidence and associated risk factors of congenital hydrocephalus.Entities:
Keywords: case control; congenital anomaly; hydrocephalus; nervous system
Year: 2022 PMID: 35592592 PMCID: PMC9112341 DOI: 10.2147/PHMT.S364447
Source DB: PubMed Journal: Pediatric Health Med Ther ISSN: 1179-9927
Univariate Analysis of the Association Between CHC and Sociodemographic Factors (Cases N = 34) and (Controls n = 102)
| Variables | Frequency No (%) | COR | 95% CI | p-value | ||
|---|---|---|---|---|---|---|
| Controls | Cases | |||||
| Maternal age | ≤ 20 | 4 (3.9) | 3 (8.8) | 0.75 | 0.06–8.83 | 0.819 |
| 21–25 | 46 (45.1) | 17 (50) | 0.37 | 0.05–2.84 | 0.338 | |
| 26–30 | 33 (32.4) | 8 (23.5) | 0.242 | 0.03–1.99 | 0.187 | |
| 31–35 | 17 (16.7) | 4 (11.8) | 0.235 | 0.03–2.22 | 0.206 | |
| > 35 | 2 (2) | 2 (5.9) | Ref | |||
| Educational background | No formal Education | 5 (4.9) | 2 (5.9) | 1.2 | 0.19–7.29 | 0.843 |
| Elementary (grade1-8) | 26 (25.5) | 9 (26.5) | 1.04 | 0.36–3.03 | 0.945 | |
| High school (grade 9–12) | 44 (43.1) | 14 (41.2) | 0.96 | 0.36–2.51 | 0.925 | |
| College and above | 27 (26.5) | 9 (26.5) | Ref | |||
| Ethnicity | Amhara | 93 (91.2) | 31 (91.2) | 2 | 0.23–17.23 | 0.529 |
| Oromo | 3 (2.9) | 2 (5.9) | 4 | 0.25–63.9 | 0.327 | |
| Tigre | 6 (5.9) | 1 (2.9) | Ref | |||
| Residence | Urban | 78 (76.5) | 25 (73.5) | 0.855 | 0.35–2.08 | 0.729 |
| Rural | 24 (23.5) | 9 (26.5) | Ref | |||
| Occupation | Factory worker | 6 (5.9) | 4 (11.8) | 2.133 | 0.56–8.07 | 0.264 |
| Non-factory worker | 96 (94.1) | 30 (88.2) | Ref | |||
Abbreviations: COR, crude odds ratio; CI, confidence interval; Ref, reference.
Univariate Analysis of the Association of Risk Factors and Occurrence of CHC (Cases N = 34) and (Controls n = 102)
| Variables | Frequency No (%) | COR | 95% CI | p-value | ||
|---|---|---|---|---|---|---|
| Controls | Cases | |||||
| Sex of the fetus | Male | 52 (51) | 14 (41.2) | 0.673 | 0.31–1.48 | 0.323 |
| Female | 50 (49) | 20 (58.8) | Ref | |||
| Any alcohol intake during pregnancy | No | 94 (92.2) | 26 (76.5) | Ref | ||
| Yes | 8 (7.8) | 8 (23.5) | 3.62 | 1.24–10.6 | 0.019 | |
| Any khat chewing during pregnancy | No | 91 (89.2) | 28 (82.4) | Ref | ||
| Yes | 11 (10.8) | 6 (17.6) | 1.773 | 0.6–5.23 | 0.299 | |
| ANC follow-up | No | 13 (12.7) | 6 (17.6) | Ref | ||
| Yes | 89 (87.3) | 28 (82.4) | 0.682 | 0.24–1.96 | 0.299 | |
| Iron and folic acid supplementation during pregnancy | No | 18 (17.6) | 15 (44.1) | Ref | ||
| Yes | 84 (82.4) | 19 (55.9) | 0.271 | 0.12–0.63 | 0.003 | |
| Consanguinity | No | 100 (98) | 32 (94.1) | Ref | ||
| Yes | 2 (2) | 2 (5.9) | 3.13 | 0.42–23.1 | 0.264 | |
| Presence of any disease during pregnancy | No | 87 (85.3) | 24 (70.6) | Ref | ||
| Yes | 15 (14.7) | 10 (29.4) | 2.42 | 0.96–6.06 | 0.06 | |
| Any drug intake during pregnancy | No | 88 (86.3) | 24 (70.6) | Ref | ||
| Yes | 14 (13.7) | 10 (29.4) | 2.62 | 1.04–6.63 | 0.042 | |
Abbreviations: COR, crude odds ratio; CI, confidence interval; Ref, reference.
Figure 1Congenital anomalies/clinical conditions present in association with case and control fetuses, respectively. Numbers indicate relative percentage for the occurrence of each anomaly.
Multivariate Analysis of the Association Between Risk Factors and Presence of Congenital Hydrocephalus (Cases N = 34) and (Controls n = 102)
| Variables | Frequency No (%) | AOR | 95% CI | p-value | ||
|---|---|---|---|---|---|---|
| Controls | Cases | |||||
| Maternal age | ≤ 20 | 4 (3.9) | 3 (8.8) | 0.361 | 0.02–6.11 | 0.48 |
| 21–25 | 46 (45.1) | 17 (50) | 0.426 | 0.05–3.78 | 0.444 | |
| 26–30 | 33 (32.4) | 8 (23.5) | 0.354 | 0.38–3.31 | 0.362 | |
| 31–35 | 17 (16.7) | 4 (11.8) | 0.134 | 0.01–1.59 | 0.111 | |
| > 35 | 2 (2) | 2 (5.9) | Ref | |||
| Any alcohol intake during pregnancy | No | 94 (92.2) | 26 (76.5) | Ref | ||
| Yes | 8 (7.8) | 8 (23.5) | 7.64 | 1.97–29.66 | 0.003* | |
| Iron and folic acid supplementation during pregnancy | No | 18 (17.6) | 15 (44.1) | Ref | ||
| Yes | 84 (82.4) | 19 (55.9) | 0.186 | 0.07–0.49 | 0.001* | |
| Presence of any disease during pregnancy | No | 87 (85.3) | 24 (70.6) | Ref | ||
| Yes | 15 (14.7) | 10 (29.4) | 0.965 | 0.12–7.72 | 0.973 | |
| Any drug intake during pregnancy | No | 88 (86.3) | 24 (70.6) | Ref | ||
| Yes | 14 (13.7) | 10 (29.4) | 4.433 | 0.53–36.9 | 0.169 | |
Note: *Significant p-value.
Abbreviations: AOR, adjusted odds ratio; CI, confidence interval; Ref, reference.
Association Between Congenital Hydrocephalus and Exposure to Risk Factors During Pregnancy (Cases N = 34) and (Controls n = 102)
| Variables | Frequency, No (%) | OR | 95% CI | p-value | |||
|---|---|---|---|---|---|---|---|
| Controls | Cases | ||||||
| Disease exposure during pregnancy | Typhus and Typhoid | Yes | 5 (4.9) | 7 (20.6) | 5.03 | 1.48–17.11 | 0.01 |
| Hypertension | Yes | 2 (2) | 2 (5.9) | ♦ | |||
| Asthma | Yes | 2 (2.4) | 0 | ♦ | |||
| Febrile illness | Yes | 1 (1) | 2 (5.9) | ♦ | |||
| Gastritis | Yes | 4 (4.9) | 2 (5.9) | ♦ | |||
| UTI | Yes | 3 (3.7) | 0 | ♦ | |||
| STI | Yes | 1 (1) | 0 | ♦ | |||
| Drugs used during pregnancy | Antihypertensive drug | Yes | 1(1) | 2 (5.9) | ♦ | ||
| Drug for Typhus and Typhoid | Yes | 3 (2.9) | 2 (5.9) | ♦ | |||
| Antiasthmatic | Yes | 2 (2) | 0 | ♦ | |||
| Drug for febrile illness | Yes | 1 (1) | 0 | ♦ | |||
| Antiacid | Yes | 4 (3.9) | 2 (5.9) | ♦ | |||
| Antibiotic | Yes | 3 (2.9) | 5 (14.7) | 5.69 | 1.28–25.26 | 0.02 | |
| Antifungal | Yes | 1 (1) | 0 | ♦ | |||
Abbreviations: OR, odds ratio; CI, confidence interval; UTI, urinary tract infection; STI, sexually transmitted infection ♦ p >0.05 (not significant).